Notices and Activity Reports

【Report vol.6】5th Annual Conference NanoGAS® Water Research Report

Report on the 5th Annual Meeting <vol.6>

“Research on the Application and Practical Use of Ultra Fine Bubble NanoGAS® in the Medical Field”

Risako Morishita, Symbiosis Research Institute

Synbiosis reported on the NanoGAS® Water study.

NanoGAS®, which is utilized for intestinal flora transplantation (FMT), has an excellent track record in the treatment of a wide range of diseases, including not only intestinal diseases such as irritable bowel syndrome and ulcerative colitis, but also skin diseases such as atopy and allergies, and mental disorders such as depression and autism.

Scientific validation of NanoGAS®︎-FMT is underway, with a scientific paper on its efficacy against diabetic diseases being published in 2020. Among microbubbles, Nanobubble, with its special physical properties, is expected to have further potential to make a significant contribution to health science in general.

Therefore, we started various basic researches in 2020 to utilize NanoGAS®︎ in the fields of medicine, drug discovery, and food, and reported new findings on three research themes in the fields of medicine, drug discovery, and food this time.

Articles about other Notices and Activity Reports

November 16, 2026

10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]

The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 06, 2026

Survey Summary from the 10th Annual Academic Conference

The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

October 28, 2024

〈Clinical Trial〉Completion Report

We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]